184 related articles for article (PubMed ID: 38460375)
1. Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma.
Huang Q; Zhong X; Li J; Hu R; Yi J; Sun J; Xu Y; Zhou X
Biomed Pharmacother; 2024 Apr; 173():116409. PubMed ID: 38460375
[TBL] [Abstract][Full Text] [Related]
2. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
Li C; Xu X
Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
[TBL] [Abstract][Full Text] [Related]
3. An emerging research: the role of hepatocellular carcinoma-derived exosomal circRNAs in the immune microenvironment.
Xu HZ; Lin XY; Xu YX; Xue HB; Lin S; Xu TW
Front Immunol; 2023; 14():1227150. PubMed ID: 37753074
[TBL] [Abstract][Full Text] [Related]
4. Exosomal ncRNAs facilitate interactive 'dialogue' between tumor cells and tumor-associated macrophages.
Zhou X; Liu Q; Wang X; Yao X; Zhang B; Wu J; Sun C
Cancer Lett; 2023 Jan; 552():215975. PubMed ID: 36306940
[TBL] [Abstract][Full Text] [Related]
5. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.
Xu Z; Chen Y; Ma L; Chen Y; Liu J; Guo Y; Yu T; Zhang L; Zhu L; Shu Y
Mol Ther; 2022 Oct; 30(10):3133-3154. PubMed ID: 35405312
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers.
Jia Z; Jia J; Yao L; Li Z
Front Immunol; 2022; 13():900155. PubMed ID: 35663957
[TBL] [Abstract][Full Text] [Related]
7. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
8. Crosstalk between colorectal cancer cells and cancer-associated fibroblasts in the tumor microenvironment mediated by exosomal noncoding RNAs.
Sun S; Zhang Y; Li Y; Wei L
Front Immunol; 2023; 14():1161628. PubMed ID: 37234178
[TBL] [Abstract][Full Text] [Related]
9. The immunosuppressive tumor microenvironment in hepatocellular carcinoma-current situation and outlook.
Zhou Z; Hu Y; Wu Y; Qi Q; Wang J; Chen L; Wang F
Mol Immunol; 2022 Nov; 151():218-230. PubMed ID: 36179604
[TBL] [Abstract][Full Text] [Related]
10. Exosomal non-coding RNAs: Emerging roles in bilateral communication between cancer cells and macrophages.
Li W; Wang X; Li C; Chen T; Yang Q
Mol Ther; 2022 Mar; 30(3):1036-1053. PubMed ID: 34864204
[TBL] [Abstract][Full Text] [Related]
11. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.
Wang W; Hao LP; Song H; Chu XY; Wang R
Front Oncol; 2022; 12():790916. PubMed ID: 35280805
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome.
Afra F; Mahboobipour AA; Salehi Farid A; Ala M
Biomed Pharmacother; 2023 Sep; 165():115104. PubMed ID: 37393866
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of miR-4669 Enhances Tumor Aggressiveness and Generates an Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma: Its Clinical Value as a Predictive Biomarker.
Nakano T; Chen CL; Chen IH; Tseng HP; Chiang KC; Lai CY; Hsu LW; Goto S; Lin CC; Cheng YF
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175615
[TBL] [Abstract][Full Text] [Related]
15. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
Fang Z; Xu J; Zhang B; Wang W; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Nov; 13(1):154. PubMed ID: 33213510
[TBL] [Abstract][Full Text] [Related]
16. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications.
Tang XH; Guo T; Gao XY; Wu XL; Xing XF; Ji JF; Li ZY
Mol Cancer; 2021 Jul; 20(1):99. PubMed ID: 34330299
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived or non-tumor-derived exosomal noncodingRNAs and signaling pathways in tumor microenvironment.
Wu Y; Niu D; Deng S; Lei X; Xie Z; Yang X
Int Immunopharmacol; 2022 May; 106():108626. PubMed ID: 35189470
[TBL] [Abstract][Full Text] [Related]
18. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
Wu Q; Zhou L; Lv D; Zhu X; Tang H
J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
[TBL] [Abstract][Full Text] [Related]
19. Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells.
Huang M; Huang X; Huang N
Cancer Sci; 2022 Jun; 113(6):1968-1983. PubMed ID: 35396771
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
